News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Poole Sandra
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Poole Sandra (Director) has filed a Form 4 on Travere Therapeutics, Inc.|
Txns:
| Granted 4,500 shares
@ $0
Granted 13,500 options to buy
@ $17.11, valued at
$231k
|
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2020 |
4
| Poole Sandra (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 9,000 options to buy
@ $15.43, valued at
$138.9k
|
|
| 05/15/2019 |
4
| Poole Sandra (Director) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 3,500 shares
@ $0
Granted 14,000 options to buy
@ $17.87, valued at
$250.2k
|
|
| 05/15/2019 |
3
| Poole Sandra (Director) has filed a Form 3 on Retrophin, Inc. |
| 10/24/2018 |
4/A
| Poole Sandra (COO) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 77,500 options to buy
@ $10, valued at
$775k
|
|
| 10/22/2018 |
4
| Poole Sandra (COO) has filed a Form 4 on LogicBio Therapeutics, Inc.|
Txns:
| Granted 106,262 options to buy
@ $10, valued at
$1.1M
|
|
| 10/18/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/20/2016 |
4
| Poole Sandra (Senior VP, Tech Operations) has filed a Form 4 on IMMUNOGEN INC|
Txns:
| Granted 110,000 options to buy
@ $3.05, valued at
$335.5k
|
|
|
|